Malcolm Gillies
Directeur/Membre du Conseil chez INTUITIVE INVESTMENTS GROUP PLC
Fortune : 249 638 $ au 31/05/2024
Profil
Malcolm John Gillies is currently a Director at Ohmedics Ltd., Recyclatech Group Ltd., Plasmox Ltd., Recircle Ltd., and Changingday Ltd.
He is also the Secretary & Independent Non-Executive Director at Intuitive Investments Group Plc.
In the past, he has served as an Independent Non-Executive Director at Trading Emissions Plc, Non-Executive Director at Aircraft Medical Ltd., NovaBiotics Ltd., Antoxis Ltd., and Collagen Solutions (US) LLC.
He has also been the Secretary & Non-Executive Director at Healthcare Investment Opportunities Plc, Director at Tyre Tech Ltd.
and Roadvert Ltd., Secretary at IdMos Plc, and Secretary at Axis-Shield Ltd.
Additionally, he has worked as the Head-Funds & Financial Services Division at Shepherd & Wedderburn LLP.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/09/2023 | 145 238 ( 0,07% ) | 249 638 $ | 31/05/2024 |
Postes actifs de Malcolm Gillies
| Sociétés | Poste | Début |
|---|---|---|
| INTUITIVE INVESTMENTS GROUP PLC | Directeur/Membre du Conseil | 11/06/2020 |
| Recircle Ltd. | Directeur/Membre du Conseil | - |
| Plasmox Ltd. | Directeur/Membre du Conseil | - |
Recyclatech Group Ltd.
 Recyclatech Group Ltd. Industrial SpecialtiesProcess Industries Recyclatech Group Ltd. develops a unique patented devulcanisation technology. The private company is based in Edinburgh, UK. | Directeur/Membre du Conseil | - |
| Ohmedics Ltd. | Directeur/Membre du Conseil | - |
| Changingday Ltd. | Directeur/Membre du Conseil | - |
Anciens postes connus de Malcolm Gillies
| Sociétés | Poste | Fin |
|---|---|---|
Aircraft Medical Ltd.
 Aircraft Medical Ltd. Medical SpecialtiesHealth Technology Aircraft Medical Ltd. develops and produces medical devices that focus on the needs of anesthesia and critical care professionals. It offers video scope, video laryngoscope, medical device, laryngoscope, difficult intubation, camera stick, airway management and difficult airway management. The company was founded by Matthew John Ross McGrath in June 2001 and is headquartered in Edinburgh, the United Kingdom. | Directeur/Membre du Conseil | 01/11/2015 |
Healthcare Investment Opportunities Plc
 Healthcare Investment Opportunities Plc Financial ConglomeratesFinance Healthcare Investment Opportunities Plc operates as a development stage company and has not yet commenced principal operations. The company's principal business activities are that of an investing company focusing on opportunities in the healthcare sector. Healthcare Investment Opportunities was founded on March 15, 2013 and is headquartered in Manchester, the United Kingdom. | Directeur/Membre du Conseil | 15/02/2014 |
| TRADING EMISSIONS PLC | Directeur/Membre du Conseil | 02/12/2011 |
| ░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INTUITIVE INVESTMENTS GROUP PLC | Finance |
| Entreprise privées | 16 |
|---|---|
IdMos Plc
 IdMos Plc Medical SpecialtiesHealth Technology IdMos Plc engages in research, development and commercialization of its disease detection and monitoring technology. The company is headquartered in Dundee, the United Kingdom. | Health Technology |
NovaBiotics Ltd.
 NovaBiotics Ltd. Pharmaceuticals: MajorHealth Technology NovaBiotics Ltd. operates as a clinical-stage biotechnology firm. It designs and develops antifungal and antibacterial therapeutics for medically unmet fungal, bacterial, and polymicrobial conditions. It offers clinical and preclinical product candidates to treat clinically challenging infections that include NP213 (Novexatin) phase IIb-ready potent topical treatment for fungal nail infections (onychomycosis); NM001 (Lynovex), a dual antibacterial-mucolytic orphan drug candidate in phase IIa clinical evaluation for cystic fibrosis; NP339 (Novamycin), an antifungal peptide agent against Candida spp and other clinically relevant yeasts/moulds; and NP432 (Novarifyn), a peptide antibacterial candidate for multi-drug resistant gram-negative and gram-positive infections. The company was founded by Deborah A. O?Neil in August 2004 and is headquartered in Aberdeen, the United Kingdom. | Health Technology |
Shepherd & Wedderburn LLP
 Shepherd & Wedderburn LLP Miscellaneous Commercial ServicesCommercial Services Shepherd & Wedderburn LLP provides legal services. The firm provides services to public Sector, rural, real estate and Infrastructure, food and drink and financial institution and banking sectors. The company was founded in 1922 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
Antoxis Ltd.
 Antoxis Ltd. BiotechnologyHealth Technology Antoxis Ltd. designs and develops synthesis therapeutic antioxidants. The firm also develops innovative approaches for the treatment of neurodegenerative conditions, cardiovascular disease, cancer and inflammatory disorders through its mitochondrial-targeted, redox technology platform. The company was founded by Andrew Scott Johnstone and Donald Barton Mcphail in March 2005 and is headquartered in Aberdeen, the United Kingdom. | Health Technology |
Trading Emissions Plc
 Trading Emissions Plc Investment Trusts/Mutual FundsMiscellaneous Trading Emissions Plc operates as a closed-end investment company. The firm engages in business of investing in environmental and emissions assets; and companies providing products and services related to the reduction of greenhouse gas emissions and associated financial products. It operates through the following segments: Carbon, Private Equity, and Corporate. The Carbon segment deals with carbon investments and carbon related trade. The Private Equity segment consists of financial assets at fair value through profit or loss-private equity. The Corporate segment covers all assets and liabilities not otherwise attributable to the Carbon or Private Equity segments. The company was founded on March 15, 2005 and is headquartered in Douglas, Isle of Man. | Miscellaneous |
| Ohmedics Ltd. | |
Recyclatech Group Ltd.
Recyclatech Group Ltd. Industrial SpecialtiesProcess Industries Recyclatech Group Ltd. develops a unique patented devulcanisation technology. The private company is based in Edinburgh, UK. | Process Industries |
Healthcare Investment Opportunities Plc
Healthcare Investment Opportunities Plc Financial ConglomeratesFinance Healthcare Investment Opportunities Plc operates as a development stage company and has not yet commenced principal operations. The company's principal business activities are that of an investing company focusing on opportunities in the healthcare sector. Healthcare Investment Opportunities was founded on March 15, 2013 and is headquartered in Manchester, the United Kingdom. | Finance |
Collagen Solutions (US) LLC
 Collagen Solutions (US) LLC BiotechnologyHealth Technology Collagen Solutions (US) LLC is a holding company, which engages in the supply, development, and manufacture of medical grade collagen components and biomaterials. The company offers products for the use in regenerative medicine, medical devices, and in-vitro diagnostics and research. It operates through the following geographical segments: Europe, Middle East, and Africa; North America; and Asia. The company was founded on March 15, 2013 and is headquartered in Glasgow, the United Kingdom. | Health Technology |
Axis-Shield Ltd.
 Axis-Shield Ltd. Medical SpecialtiesHealth Technology Axis-Shield Ltd. operates as a biotechnology company. The company was founded 1993 and is headquartered in the United Kingdom. | Health Technology |
| Plasmox Ltd. | |
| Tyre Tech Ltd. | |
| Roadvert Ltd. | |
| Recircle Ltd. | |
Aircraft Medical Ltd.
Aircraft Medical Ltd. Medical SpecialtiesHealth Technology Aircraft Medical Ltd. develops and produces medical devices that focus on the needs of anesthesia and critical care professionals. It offers video scope, video laryngoscope, medical device, laryngoscope, difficult intubation, camera stick, airway management and difficult airway management. The company was founded by Matthew John Ross McGrath in June 2001 and is headquartered in Edinburgh, the United Kingdom. | Health Technology |
| Changingday Ltd. |
